SecBot SecBot
8-KDEFA14A ·Filed Jul 2, 2026

AVNS

AVANOS MEDICAL, INC.
BULLISH
Impact 7/10
Horizonweeks Processed4mo ago SEC0001606498-26-000085
Actionable Insight ▲ Bullish

The stock should re-rate closer to the deal price as the special meeting approaches. Monitor for any dissident stockholder opposition or competing bids, but the regulatory milestone makes deal completion highly likely. The vote on July 22 is the final major hurdle.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$24.93
T+0 close · Jul 2, 2026 · via day close
Latest settled
+0.04%
T+5 · $24.94
Vs SPY
−0.89%
α at T+5
Next horizon
T+1
due 4mo ago
  1. T+0 · Jul 2 $24.93entry
  2. T+1 · due 4mo ago Pending
  3. T+5 · 4mo ago +0.04%α −0.89% · $24.94
  4. T+20 · due 4mo ago Pending
  5. T+60 · due 7w ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Avanos Medical received all required regulatory approvals for its pending acquisition by American Industrial Partners (AIP). The special stockholder meeting to approve the deal is set for July 22, 2026, with closing expected by July 27. This removes a key condition precedent, significantly reducing deal risk.

Key Facts

  • All required regulatory approvals received for the AIP acquisition
  • Special stockholder meeting scheduled for July 22, 2026
  • Transaction expected to close no later than July 27, 2026
  • Merger agreement dated April 13, 2026

Financial Impact

Regulatory clearance removes a major closing condition. The all-cash acquisition at a premium to pre-announcement price should narrow the spread. Deal value is not disclosed in these filings, but Avanos had a $1.2B market cap as of the filing date.

dealSpreadclosingProbability

Risk Factors

  • Stockholder vote could fail to approve the merger
  • A competing bid could emerge before the vote
  • Remaining customary closing conditions may not be satisfied or waived

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 9 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (AVNS), Batch item 10001606498-26-000085
Document: avnsform8k_07022026xex991.htm0001606498-26-000086
Document: 0001606498-26-000085-index-headers.html0001606498-26-000085
Document: 0001606498-26-000085-index.html0001606498-26-000085
Document: 0001606498-26-000085.txt0001606498-26-000085
DEFA14A Filing (AVNS), Batch item 60001606498-26-000086
Document: 0001606498-26-000086-index-headers.html0001606498-26-000085
Document: 0001606498-26-000086-index.html0001606498-26-000085
Document: 0001606498-26-000086.txt0001606498-26-000085

Track record

7 reports on AVNS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Jul 27, 202616w ago 25-NSE Neutral 5/10 Entry $24.99 No price data
  2. Jul 2, 202619w ago 8-K / DEFA14A Bullish 7/10 Viewing Entry $24.93 to $24.94 ▲ +0.04% −0.89% vs SPY
  3. Jun 10, 202622w ago DEFM14A Bullish 8/10 Entry $24.98 to $24.87 ▼ −0.44% −0.87% vs SPY
  4. May 5, 202627w ago DEFA14A Neutral 5/10 Entry $24.72 to $24.73 ▲ +0.04% −1.09% vs SPY
  5. Apr 23, 202629w ago DEFA14A Bullish 8/10 Entry $24.71 to $24.65 ▼ −0.24% −1.72% vs SPY
  6. Apr 14, 202630w ago DEFA14A Neutral 4/10 Entry $24.63 to $24.64 ▲ +0.04% −1.35% vs SPY
  7. Feb 26, 202637w ago 8-K Neutral 5/10 Entry $14.49 to $13.79 ▼ −4.83% −3.70% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 6h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026